Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<keyword id="6358777" type="LOCATION" weightage="20" keywordseo="New-Delhi">New Delhi</keyword>, <keyword id="472760" type="PERSON" weightage="20" keywordseo="Indian-pharma-companies">Indian pharma companies</keyword> are expected to benefit from improving demand in the US market, said <keyword id="1498859" type="COMPANY" weightage="20" keywordseo="India-Ratings-and-Research">India Ratings and Research</keyword> (Ind-Ra).<br /><br />As per the ratings agency, these companies have garnered 45% of all new Abbreviated New Drug Application (ANDA) approvals over the past nine months.<br /><br />Besides, Ind-Ra expects the regulatory environment to remain stringent.<br /><br />However, it said well-equipped companies would be able to take the advantage of a better pricing outlook emanating from supply shortages and recalls.<br /><br />"Indian companies have received a higher share of new ANDA approvals since April 2020 led by significant manufacturing facility clearances, GDUFA-II (Generic Drug User Fee Amendments), and a strong filing momentum aided by historical investments in R&amp;D," Ind-Ra added in a report.<br /><br />"Ind-Ra has seen an increasing drug demand since the start of the <keyword id="8902449" type="UNKNOWN" weightage="20" keywordseo="covid-19-pandemic">Covid-19 pandemic</keyword> led by supply chain issues, channel filling, and demand for Covid-19 led <keyword id="10461594" type="UNKNOWN" weightage="20" keywordseo="preventive-products">preventive products</keyword>. In the past, too, there was <keyword id="937715" type="PERSON" weightage="20" keywordseo="drug-shortage">drug shortage</keyword> in the US due to the exit of the large generic players from unviable products."<br /><br />"Overall drug shortages in the US are leading to moderate-to-stable pricing pressures."<br /><br />Furthermore, it cited that majority of the drug recalls (91%) from the US markets are from the non or least serious category (Class-II and III recall).<br /><br />Accordingly, only 'Class-I' drug recalls are serious in nature.<br /><br /><strong>SEE ALSO:<br /><a href="https://www.businessinsider.in/business/news/ikea-india-cfo-says-she-still-has-3500-crore-to-be-spent-in-india-the-pandemic-has-changed-targets-but-not-the-investment-plan/articleshow/79790938.cms">INTERVIEW: Ikea CFO says she still has ₹3,500 crore to be spent in India⁠— the pandemic has changed targets but not the investment plan</a><br /><a href="https://www.businessinsider.in/science/health/news/india-will-produce-300-million-doses-of-the-russian-sputnik-v-covid-19-vaccine-next-year/articleshow/79795341.cms">India will produce 300 million doses of the Russian Sputnik V COVID-19 vaccine next year</a><br /><a href="https://www.businessinsider.in/stock-market/news/how-to-check-mrs-bectors-food-specialities-ipo-allotment-status-online/articleshow/79808672.cms">Mrs Bectors Food Specialities IPO allotment: Here’s how to check share allotment status</a></strong><br />

Indian pharma companies to benefit from increasing demand in US, says report

<p><div class="KonaFilter image-container display-table float_right"><div><div class="image on-image"><p class="source"><span>Thomson Reuters</span></p><p class="caption">Traders work on the floor of the NYSE</p></div><p></p></div></div>Via Dave Lutz at JonesTrading, here's a quick guide to what traders are chattering about on Thursday morning:</p><p style="padding-left: 60px;"><span>Good Morning!  US Futures have surrendered overnight gains of nearly 1% despite some solid earnings reports (FB up 11%, BABA 7%, F 3%) as European markets dive deeper in the red.   We have the DAX and STOXX off 1.7% with every major sector in the red - not even higher Oil prices is helping Energy stay green.  FX skews remain in the spotlight after AAPL y'day, with the strong Swissie killing Roche #s, weighing on the overall healthcare sector.   The still HATE the Financials overseas, with EU Banks off nearly 3% and several Italian banks are limit down.  In London, the FTSE was quickly rejected from 6000, with only the Miners strong on the FTSE with Anglo up 10% on headlines.   Volumes are pacing slightly heavier than what we have seen thus far in 2016 on average.  In Asia, Chinese stocks closed at a fresh one-year low overnight after another round of panic selling- Shanghai lost almost 3% as steel, telecommunication and computer service sectors led the decline, while Japan lost 70bp ahead of the BoJ and Aussie gained 60bp as resource stocks continued to see a cover.   While Samsung #s weighed in Korea, the KOSPI closed well bid and Emerging Markets finished at a 2week high.</span><span> </span></p><p style="padding-left: 60px;">I am seeing some Haven buying early, with the 10YY back under 2% in the states, following German Yields south.  Gold is picking its head up, nearing unchanged after overnight weakness, while the Euro is seeing a bid as leverage is drawn-down.   Keep an eye on the Yen - Stunning it remains near $/Y 119 as Japan's economy minister resigned due to scandal - The Doves are firmly in charge in Tokyo and Kuroda may not be able to satisfy their demands.   The DXY is lower as Fed Funds show only a 16% of a March Hike, down from 33% pre-Fed yesterday.   The Oil complex is holding yesterday's gains as headers persist of a OPEC/Russia meeting next month - while the cover bid has vanished from Natty as yesterday's expiry action fades and warmer weather is projected.   The Metals are mixed, with Gold and Platinum higher, but copper reversing this week's china-induced gains.   Softs are weaker across the board.<span> </span></p><p style="padding-left: 60px;">Ahead of us today, we get Weekly Jobless Claims and Durable Goods Orders at <span class="aBn" data-term="goog_120665720"><span class="aQJ">8:30</span></span>, ahead of the Pending Home Sales data at 10.  <span class="aBn" data-term="goog_120665721"><span class="aQJ">10:30</span></span> brings us Natty gas Inventory data - and at <span class="aBn" data-term="goog_120665722"><span class="aQJ">1pm</span></span> the US Treasury auctions off $29B in 7Y Notes.   Earnings remains in focus (ABT, BMY, CELG, LLY / BX, IVZ, TROW / BABA, TWC / POT / CAT, F, JBLU / UA, MO. HSY / BHI pre open - while we get AMGN / AMZN, ERTS, MSFT, KLAC, WDC / V <span class="aBn" data-term="goog_120665723"><span class="aQJ">tonight</span></span>).  Down in Washington, we have a Senate Finance Cmte hearing on retirement savings plans at <span class="aBn" data-term="goog_120665724"><span class="aQJ">9:30</span></span>, and a Senate Health, Education, Labor and Pensions Cmte hearing on generic drug user fee amendments and access to generic drug at 10.  We have no Fed speakers - attention firmly on <span class="aBn" data-term="goog_120665725"><span class="aQJ">tomorrow</span></span> afternoon where Fed's Williams gives a forecast speech in San Francisco.</p>    <div class="margin-top">        <h3>NOW WATCH: <a href="http://www.businessinsider.com/reasons-men-cheat-research-adultery-gary-neuman-2016-1">Research reveals why men cheat - and it's not what you think</a></h3>        <div>            <div>        <div class="ooyala-video-player" data-video-autoplay="false" data-video-id="9vdnlycjo8Di2vj5XaYNQCb3Cc2NYbee" data-player-variable="ooyalapopvideo" id="ooyalaplayer_popvideo" style="width:1280px;height:720px"></div>        </div>        </div>            </div>

Here's a super quick guide to what traders are talking about right now

'That's Not All!' Kevin Trudeau, The World's Greatest Salesman, Makes One Last Pitch

You Searched For "gdufa ii generic drug user fee amendments" and got 3 results

Indian pharma companies to benefit from increasing demand in US, says report

IANS

Here's a super quick guide to what traders are talking about right now

Akin Oyedele

'That's Not All!' Kevin Trudeau, The World's Greatest Salesman, Makes One Last Pitch

Aaron Gell

Popular Keywords

Buying Guides